BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16220669)

  • 41. Cortisol concentrations following stimulation of healthy and adrenopathic dogs with two doses of tetracosactrin.
    Frank LA; DeNovo RC; Kraje AC; Oliver JW
    J Small Anim Pract; 2000 Jul; 41(7):308-11. PubMed ID: 10976626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma aldosterone concentrations and plasma renin activity in healthy dogs and dogs with hyperadrenocorticism.
    Javadi S; Kooistra HS; Mol JA; Boer P; Boer WH; Rijnberk A
    Vet Rec; 2003 Oct; 153(17):521-5. PubMed ID: 14620551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
    Nelson RW; Feldman EC; Shinsako J
    Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia.
    Peterson ME; Gilbertson SR; Drucker WD
    J Am Vet Med Assoc; 1982 Mar; 180(5):542-4. PubMed ID: 6277837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrasonography criteria for differentiating ACTH dependency from ACTH independency in 47 dogs with hyperadrenocorticism and equivocal adrenal asymmetry.
    Benchekroun G; de Fornel-Thibaud P; Rodríguez Piñeiro MI; Rault D; Besso J; Cohen A; Hernandez J; Stambouli F; Gomes E; Garnier F; Begon D; Maurey-Guenec C; Rosenberg D
    J Vet Intern Med; 2010; 24(5):1077-85. PubMed ID: 20666982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma ACTH precursors in cats with pituitary-dependent hyperadrenocorticism.
    Benchekroun G; de Fornel-Thibaud P; Dubord M; Dossin O; Fracassi F; Rannou B; Garnier F; Maurey-Guenec C; Daminet S; Rosenberg D
    J Vet Intern Med; 2012; 26(3):575-81. PubMed ID: 22490046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cortisol Concentrations in Well-Regulated Dogs with Hyperadrenocorticism Treated with Trilostane.
    Midence JN; Drobatz KJ; Hess RS
    J Vet Intern Med; 2015; 29(6):1529-33. PubMed ID: 26374943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism.
    Aldridge C; Behrend EN; Kemppainen RJ; Lee-Fowler TM; Martin LG; Ward CR; Bruyette D; Pannu J; Gaillard P; Lee HP
    J Vet Intern Med; 2016 Sep; 30(5):1637-1641. PubMed ID: 27425787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study of the effects of once daily doses of trilostane on cortisol concentrations and responsiveness to adrenocorticotrophic hormone in hyperadrenocorticoid dogs.
    Bell R; Neiger R; McGrotty Y; Ramsey IK
    Vet Rec; 2006 Aug; 159(9):277-81. PubMed ID: 16946310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
    Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
    Vet Rec; 2008 Oct; 163(16):477-81. PubMed ID: 18931355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the urinary cortisol: creatinine ratio in the diagnosis of hyperadrenocorticism in dogs.
    Jensen AL; Iversen L; Koch J; Høier R; Petersen TK
    J Small Anim Pract; 1997 Mar; 38(3):99-102. PubMed ID: 9097240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum cortisol concentrations in dogs with pituitary-dependent hyperadrenocorticism and atypical hyperadrenocorticism.
    Frank LA; Henry GA; Whittemore JC; Enders BD; Mawby DI; Rohrbach BW
    J Vet Intern Med; 2015 Jan; 29(1):193-9. PubMed ID: 25411029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical evaluation of combined dexamethasone suppression/ACTH stimulation testing in dogs with hyperadrenocorticism, using HPLC for plasma cortisol determination.
    Regnier A; Alvinerie M; Toutain PL
    Zentralbl Veterinarmed A; 1988 Jul; 35(6):409-16. PubMed ID: 2844039
    [No Abstract]   [Full Text] [Related]  

  • 54. Lack of association between clinical signs and laboratory parameters in dogs with hyperadrenocorticism before and during trilostane treatment.
    Boretti FS; Holzthüm J; Reusch CE; Sieber-Ruckstuhl NS
    Schweiz Arch Tierheilkd; 2016 Sep; 158(9):631-638. PubMed ID: 27655162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of dexamethasone or synthetic ACTH administration on endogenous ACTH concentrations in healthy dogs.
    Bugbee AC; Smith JR; Ward CR
    Am J Vet Res; 2013 Nov; 74(11):1415-20. PubMed ID: 24168307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of individual low-dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs.
    Bennaim M; Shiel RE; Forde C; Mooney CT
    J Vet Intern Med; 2018 May; 32(3):967-977. PubMed ID: 29498108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs.
    Macfarlane L; Parkin T; Ramsey I
    Vet Rec; 2016 Dec; 179(23):597. PubMed ID: 27803375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
    Ford SL; Feldman EC; Nelson RW
    J Am Vet Med Assoc; 1993 Mar; 202(5):789-92. PubMed ID: 8454518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma free cortisol concentrations in dogs with hyperadrenocorticism.
    Kemppainen RJ; Peterson ME; Sartin JL
    Am J Vet Res; 1991 May; 52(5):682-6. PubMed ID: 1649561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
    Ruckstuhl NS; Nett CS; Reusch CE
    Am J Vet Res; 2002 Apr; 63(4):506-12. PubMed ID: 11939311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.